MedTrace Logo

Evaluating Safety and Effectiveness of Octenidine Dihydrochloride

NCT03140254 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 145

Last updated 2025-12-11

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the safety and effectiveness of a topical antiseptic for preoperative skin preparation

Conditions

  • Preoperative Skin Preparation

Interventions

DRUG

Chlorhexidine gluconate

DRUG

N,N'-(1,10-decanediyldi-1(4H)-Pyridinyl-4-ylidene)-Bis-(1-octanamine) Dihydrochloride

DRUG

Placebo

Sponsors & Collaborators

  • C. R. Bard

    lead INDUSTRY

Principal Investigators

  • Kevin Burroughs · Becton, Dickinson and Company

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-03-17
Completion
2017-03-17
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03140254 on ClinicalTrials.gov